Shaopeng Qiu

1.0k citations
38 papers · 782 indexed · h-index 18
Topics
Prostate Cancer Treatment and Research (7 papers)Cancer Cells and Metastasis (4 papers)Cancer-related molecular mechanisms research (4 papers)

In The Last Decade

Shaopeng Qiu

37 papers receiving 774 citations

Peers

Shaopeng Qiu
Comparison fields: 5 of 77
  • Molecular Biology 468
  • Cancer Research 233
  • Oncology 194
  • Pulmonary and Respiratory Medicine 178
  • Surgery 155
Replace Toshinori Oka with:
Toshinori Oka Japan
Mercedes Marín‐Aguilera Spain
M. Bianchi Italy
Tulio Matos United States
Fujun Zhao China
Debra M. Sutkowski United States
Daizo Oka Japan
Masafumi Kumano Japan
Niels Fristrup Denmark
Weihong Ding China
Shaopeng Qiu relative to Toshinori Oka Japan Toshinori Oka's profile →
Citations per field
00.5×6.6×
Toshinori Oka · 1×
Citations per year

Countries citing papers authored by Shaopeng Qiu

Since Specialization
Citations

This map shows the geographic impact of Shaopeng Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaopeng Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaopeng Qiu more than expected).

Fields of papers citing papers by Shaopeng Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaopeng Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaopeng Qiu. The network helps show where Shaopeng Qiu may publish in the future.

Co-authorship network of co-authors of Shaopeng Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Shaopeng Qiu. A scholar is included among the top collaborators of Shaopeng Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaopeng Qiu. Shaopeng Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 7
4 39
5 20
6 9
7 53
8 50
9 21
10 75
11 17
12 25
13 2
14 42
15 23
16 26
17 0
18 23
19 5
20
A preliminary study on the artificial cultivation and breeding selection of Suaeda salsa
3

About Shaopeng Qiu

Shaopeng Qiu is a scholar working on Cancer Research, Urology and Immunology and Allergy, having authored 38 papers that have together received 782 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (7 papers), Cancer Cells and Metastasis (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (233 citations), Urology (88 citations) and Oncology (194 citations). Shaopeng Qiu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Bin Huang, Junxing Chen, Xiaopeng Mao, Chengqiang Mo, Daohu Wang, Jintao Zhuang, Jincheng Pan, Shengjie Guo, Jun Liao and Xu Chen. Their work appears in journals such as PLoS ONE, Frontiers in Immunology and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026